Solifenacin Provided Statistically Significant and Clinically Relevant Reductions in Urgency, a Defining Symptom of Overactive Bladder
Chapple C1, Wyndaele J2, Gronen S3, for the Solifenacin Study Group 1 1. Royal Hallamshire Hospital, Sheffield, UK, 2. Department of Urology, University Antwerpen, Belgium, 3. Yamanouchi Europe B.V., Leiderdorp, The Netherlands
|
|
Abstract 276
|
|
|
Non Discussion Posters:
Scientific Non Discussion Poster Session 19
|
|
|